LIULi, SHENHong, JIANGPeng-jun, CHENJie, LIUQing, ZHANGXu. Effects of Isoliquiritigenin on Induction of Apoptosis and Expression of ERS Related Genes in NCI-H157 Cells[J]. Journal of Nanjing University of traditional Chinese Medicine, 2016, 32(3): 264-268.
Citation: LIULi, SHENHong, JIANGPeng-jun, CHENJie, LIUQing, ZHANGXu. Effects of Isoliquiritigenin on Induction of Apoptosis and Expression of ERS Related Genes in NCI-H157 Cells[J]. Journal of Nanjing University of traditional Chinese Medicine, 2016, 32(3): 264-268.

Effects of Isoliquiritigenin on Induction of Apoptosis and Expression of ERS Related Genes in NCI-H157 Cells

More Information
  • OBJECTIVE To study the effect of isoliquiritigenin on cell proliferation, apoptosis induction, mRNA expression of endoplasmic reticulum stress related gene ATF4, DDIT3 and TNFRSF10B in NCI-H157 human lung cancer cell line. METHODS NCI-H157 cells were cultured and treated with various concentrations isoliquiritigenin. The cell proliferation was analyzed by MTT and the occurrence of cell apoptosis was examined by flow cytometry. ATF4, DDIT3 and TNFRSF10B gene mRNA expression were detected by real-time fluorescence quantitative polymerase chain reaction. RESULTS Isoliquiritigenin significantly inhibited NCI-H157 cell proliferation in a dose and time dependent manner. The results of flow cytometry revealed that isoliquiritigenin could induce apoptosis in NCI-H157 cells. Real-time quantitative RT-PCR showed that isoliquiritigenin up-regulated mRNA expression of ATF4, DDIT3 and TNFRSF10B(P<0.05~0.01). CONCLUSION Isoliquiritigenin can inhibit NCI-H157 cell proliferation, induce cell apoptosis by activating the endoplasmic reticulum stress response.
  • [1]
    陈万青,张思维,邹小农.中国肺癌发病死亡的估计和流行趋势研究[J].中国肺癌杂志,2010, 13(5):488-493.
    [2]
    Chen WQ, Zhang SW, Zou XN. Estimation and projection of lung cancer incidence and mortality in China[J]. Chin J Lung Cancer, 2010, 13(5): 488-493.
    [3]
    韩仁强,郑荣寿,张思维,等.1989年-2008年中国肺癌发病性别、城乡差异及平均年龄趋势分析[J].中国肺癌杂志,2013, 16(9):445-451.
    [4]
    Han RQ, Zheng RS, Zhang SW, et al. Trend analyses on the difference of lung cancer incidence between gender, area and average age in China during 1989-2008[J]. Chin J Lung Cancer, 2013, 16(9): 445-451.
    [5]
    徐振晔,龚亚斌.未来10余年肺癌中西医诊疗展望[J].上海中医药大学学报,2011, 25(1):10-14.
    [6]
    Xu ZY, Gong YB. Prospect on diagnosis and treatment of lung cancer of Chinese and western medicine in the next decade[J]. J Shanghai Univ Tradit Chin Med, 2011, 25(1): 10-14.
    [7]
    Honda H, Nagai Y, Matsunaga T, et al. Isoliquiritigenin is a potent inhibitor of NLRP3 inflammasome activation and diet-induced adipose tissue inflammation[J]. J Leukoc Biol, 2014, 96(6): 1087-1100.
    [8]
    Adianti M, Aoki C, Komoto M, et al. Anti-hepatitis C virus compounds obtained from Glycyrrhiza uralensis and other Glycyrrhiza species[J]. Microbiol Immunol, 2014, 58(3): 180-187.
    [9]
    Liu B, Yang J, Wen QS, et al. Isoliquiritigenin, a flavonoid from licorice, relaxes guinea-pig tracheal smooth muscle in vitro and in vivo: Role of cGMP/PKG pathway[J]. Eur J Pharmacol, 2008, 587(1/2/3): 257-266.
    [10]
    Yamamoto S, Aizu E, Jiang H, et al. The potent anti-tumor-promoting agent isoliquiritigenin[J]. Carcinogenesis, 1991, 12(2): 317-323.
    [11]
    Ramalingam SS, Owonikoko TK, Khuri FR. Lung cancer: new biological insights and recent therapeutic advances[J]. CA Cancer J Clin, 2011, 61(2): 91-112.
    [12]
    Ii T, Satomi Y, Katoh D, et al. Induction of cell cycle arrest and p21(CIP1/WAF1)expression in human lung cancer cells by isoliquiritigenin[J]. Cancer Lett, 2004, 207(1): 27-35.
    [13]
    Hsu YL, Kuo PL, Chiang LC, et al. Isoliquiritigenin inhibits the proliferation and induces the apoptosis of human non-small cell lung cancer A549 cells[J]. Clin Exp Pharmacol Physiol, 2004, 31(7): 414-418.
    [14]
    Phelps RM, Johnson BE, Ihde DC, et al. NCI-navy medical oncology branch cell line data base[J]. J Cell Biochem Suppl, 1996, 24: 32-91.
    [15]
    Yang J, Yang Y, Tian L, et al. Casticin-induced apoptosis involves death receptor 5 upregulation in hepatocellular carcinoma cells[J]. World J Gastroenterol, 2011, 17(38): 4298-4307.
    [16]
    O'connor PM, Jackman J, Bae I, et al. Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents[J]. Cancer Res, 1997, 57(19): 4285-4300.
    [17]
    Ahrendt SA, Hu YC, Buta M, et al. P53 mutations and survival in stage I non-small-cell lung cancer: results of a prospective study[J]. J Natl Cancer Inst, 2003, 95(13): 961-970.
    [18]
    Zhao LH, Ackerman SL. Endoplasmic reticulum stress in health and disease[J]. Curr Opin Cell Biol, 2006, 18(4): 444-452.
    [19]
    Jger R, Bertrand MJ, Gorman AM, et al. The unfolded protein response at the crossroads of cellular life and death during endoplasmic reticulum stress[J]. Biol Cell, 2012, 104(5): 259-270.
    [20]
    Zhao L, Longo-Guess C, Harris BS, et al. Protein accumulation and neurodegeneration in the woozy mutant mouse is caused by disruption of SIL1, a cochaperone of BiP[J]. Nat Genet, 2005, 37(9): 974-979.
    [21]
    Zinszner H, Kuroda M, Wang X, et al. CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum[J]. Genes Dev, 1998, 12(7): 982-995.
    [22]
    Pino SC, O'sullivan-Murphy B, Lidstone EA, et al. CHOP mediates endoplasmic reticulum stress-induced apoptosis in Gimap5-Deficient T cells[J]. PLoS One, 2009, 4(5): e5468.
    [23]
    Oyadomari S, Mori M. Roles of CHOP/GADD153 in endoplasmic reticulum stress[J]. Cell Death Differ, 2004, 11(4): 381-389.
    [24]
    Mccullough KD, Martindale JL, Klotz LO, et al. Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state[J]. Mol Cell Biol, 2001, 21(4): 1249-1259.
    [25]
    Liu GB, Su L, Hao XX, et al. Salermide up-regulates death receptor 5 expression through the ATF4-ATF3-CHOP axis and leads to apoptosis in human cancer cells[J]. J Cell Mol Med, 2012, 16(7): 1618-1628.
    [26]
    Schrder M, Kohno K. Recent advances in understanding the unfolded protein response[J]. Antioxid Redox Signal, 2007, 9(12): 2241-2244.
    [27]
    Liu X, Yue P, Zhou Z, et al. Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells[J]. J Natl Cancer Inst, 2004, 96(23): 1769-1780.
    [28]
    Yamaguchi H, Wang HG. CHOP is involved in endoplasmic reticulum stress-induced apoptosis by enhancing DR5 expression in human carcinoma cells[J]. J Biol Chem, 2004, 279(44): 45495-45502.
    [29]
    Li TL, Su L, Lei YJ, et al. DDIT3 and KAT2A proteins regulate TNFRSF10A and TNFRSF10B expression in endoplasmic reticulum stress-mediated apoptosis in human lung cancer cells[J]. J Biol Chem, 2015, 290(17): 11108-11118.
    [30]
    Armstrong JL, Flockhart R, Veal GJ, et al. Regulation of endoplasmic reticulum stress-induced cell death by ATF4 in neuroectodermal tumor cells[J]. J Biol Chem, 2010, 285(9): 6091-6100.
    [31]
    Jung SK, Lee MH, Lim DY, et al. Isoliquiritigenin induces apoptosis and inhibits xenograft tumor growth of human lung cancer cells by targeting both wild type and L858R/T790M mutant EGFR[J]. J Biol Chem, 2014, 289(52): 35839-35848.

Catalog

    Article Metrics

    Article views (860) PDF downloads (729) Cited by()
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return